9-128460985-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001351578.2(ODF2):c.416G>A(p.Arg139Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000719 in 1,614,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000059 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000073 ( 0 hom. )
Consequence
ODF2
NM_001351578.2 missense
NM_001351578.2 missense
Scores
4
5
10
Clinical Significance
Conservation
PhyloP100: 6.33
Genes affected
ODF2 (HGNC:8114): (outer dense fiber of sperm tails 2) The outer dense fibers are cytoskeletal structures that surround the axoneme in the middle piece and principal piece of the sperm tail. The fibers function in maintaining the elastic structure and recoil of the sperm tail as well as in protecting the tail from shear forces during epididymal transport and ejaculation. Defects in the outer dense fibers lead to abnormal sperm morphology and infertility. This gene encodes one of the major outer dense fiber proteins. Alternative splicing results in multiple transcript variants. The longer transcripts, also known as 'Cenexins', encode proteins with a C-terminal extension that are differentially targeted to somatic centrioles and thought to be crucial for the formation of microtubule organizing centers. [provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.102398306).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ODF2 | NM_001351578.2 | c.416G>A | p.Arg139Gln | missense_variant | 4/21 | ENST00000351030.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ODF2 | ENST00000351030.8 | c.416G>A | p.Arg139Gln | missense_variant | 4/21 | 2 | NM_001351578.2 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152170Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
9
AN:
152170
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251484Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135920
GnomAD3 exomes
AF:
AC:
30
AN:
251484
Hom.:
AF XY:
AC XY:
26
AN XY:
135920
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000732 AC: 107AN: 1461834Hom.: 0 Cov.: 31 AF XY: 0.0000976 AC XY: 71AN XY: 727224
GnomAD4 exome
AF:
AC:
107
AN:
1461834
Hom.:
Cov.:
31
AF XY:
AC XY:
71
AN XY:
727224
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74338
GnomAD4 genome
AF:
AC:
9
AN:
152170
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74338
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
18
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 06, 2022 | The c.416G>A (p.R139Q) alteration is located in exon 4 (coding exon 4) of the ODF2 gene. This alteration results from a G to A substitution at nucleotide position 416, causing the arginine (R) at amino acid position 139 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
.;.;.;.;T;.;.;T;.;.;.;.;.;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
D;D;D;T;.;T;.;D;T;D;D;D;D;D;D;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;.;.;M;.;.;M;M;.;.;.;M;.;.;.
MutationTaster
Benign
D;D;D;D;D;D;D;D;N
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;N;.;N;.;D;N;N;.;N;N;.;N;D
REVEL
Benign
Sift
Uncertain
.;D;D;D;.;T;.;D;D;D;.;T;D;.;D;D
Sift4G
Pathogenic
D;D;T;D;T;T;T;T;D;D;D;T;D;D;T;T
Polyphen
0.61, 0.012, 0.36, 1.0, 0.20, 1.0
.;.;P;B;B;D;B;B;D;.;.;.;D;.;B;P
Vest4
0.50, 0.45, 0.50, 0.57, 0.32, 0.33, 0.49, 0.37, 0.38
MutPred
0.43
.;Loss of phosphorylation at S58 (P = 0.0961);.;.;Loss of phosphorylation at S58 (P = 0.0961);.;.;Loss of phosphorylation at S58 (P = 0.0961);Loss of phosphorylation at S58 (P = 0.0961);Loss of phosphorylation at S58 (P = 0.0961);Loss of phosphorylation at S58 (P = 0.0961);Loss of phosphorylation at S58 (P = 0.0961);Loss of phosphorylation at S58 (P = 0.0961);Loss of phosphorylation at S58 (P = 0.0961);.;.;
MVP
MPC
0.97
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at